Inactive Instrument

News Pixarbio Corp Other OTC

Equities

US05581G1004

End-of-day quote Other OTC Other stock markets
- ^USD	-

2018	PixarBio Corporation Clarifies Pathways to FDA Approval for NR14 to Treat “Trigeminal Neuralgia” and Post-Surgical Pain	CI
2018	Pixarbio Corporation Announces the Removal of Katrin Holzhaus as Chief Administration Officer and Corporate Secretary of the Company	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

PixarBio Corporation Clarifies Pathways to FDA Approval for NR14 to Treat “Trigeminal Neuralgia” and Post-Surgical Pain	18-02-27	CI
Pixarbio Corporation Announces the Removal of Katrin Holzhaus as Chief Administration Officer and Corporate Secretary of the Company	18-02-15	CI
PixarBio Corporation announced that it has received $0.411258 million in funding	18-02-11	CI
PixarBio Corporation Announces Change of Directors	17-12-28	CI
PixarBio Corp Announces Resignation of Derek Bridges Member of Board of Directors	17-12-22	CI
PixarBio Corporation announced a financing transaction	17-11-12	CI
PixarBio Corporation announced that it has received $0.0885 million in funding	17-06-29	CI
PixarBio Corporation announced a financing transaction	17-06-14	CI
PixarBio Corporation announced that it has received $0.21 million in funding	17-05-01	CI
PixarBio Corporation announced a financing transaction	17-04-16	CI
Pixarbio Corporation Announces Termination of Robert S. Langer as a Member of Scientific Advisory Board	17-03-10	CI
PixarBio Corporation Announces Management Changes	17-02-09	CI
PixarBio Corporation cancelled the acquisition of InVivo Therapeutics Holdings Corp..	17-01-22	CI
PixarBio Corporation announced that it has received $0.3 million in funding	17-01-22	CI
Henry Sargent acquired Buddhi Mat LLC from PixarBio Corporation.	17-01-04	CI
PixarBio Corporation made a bid to acquire InVivo Therapeutics Holdings Corp. for $77 million.	17-01-02	CI
PixarBio Corporation Establishes the JP Reynolds Research Center in Woburn, MA	16-12-21	CI
PixarBio Corporation Appoints Steve Chartier as Chief Operating Officer	16-12-20	CI
PixarBio Corporation Appoints Barry Belfer as Senior Vice President of Finance	16-11-07	CI
PixarBio Corporation Auditor Raises 'Going Concern' Doubt	16-11-03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Pixarbio Corp Other OTC

Equities

US05581G1004

Summary

Filters